ISRCTN14555104已完成2 期
Phase II analysis of paclitaxel and capecitabine in the treatment of recurrent or disseminated squamous cell carcinoma of the head and neck region
Department of Oncology, Herlev Hospital0 个研究点目标入组 183 人开始时间: 2018年4月6日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 183
研究概览
简要总结
2007 results from first 50 patients in https://www.ncbi.nlm.nih.gov/pubmed/17103405
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Histologically confirmed recurrent or disseminated squamous cell carcinoma of the head and neck region, not suitable for curative radiotherapy or salvage surgery
- •2. Measurable disease in minimum 2 dimensions
- •3. Aged 18-75 years
- •4. World Health Organization (WHO) performance status <=2
- •5. No previous chemotherapy for 1 month
- •6. No other severe life-shortening disease or other malignant disease
- •7. Adequate bone marrow, liver, and renal function
排除标准
- •1. Non-measurable disease
- •2. Pregnant or breastfeeding women
- •3. Chemotherapy within the last month
- •4. Brain metastases
- •5. Other malignant disease
研究者
相似试验
已完成
2 期
A Phase II Study of Capecitabine plus Paclitaxel Combination Chemotherapy in Patients with Metastatic Breast CancerMetastatic Breast CancerJPRN-UMIN000000869KBCSG (Kinki Breast Cancer Study Group)42
已完成
2 期
Paclitaxel with or without GSK1120212 for treatment of melanomaCancerMelanomaISRCTN43327231niversity of Oxford (UK)111
已完成
2 期
Paclitaxel and Epirubicin as neoadjuvant systemic treatment for locally advanced breast cancerCancer - BreastBreast cancerACTRN12611000307909The Queen Elizabeth Hospital40
已完成
2 期
Phase II Study of Paclitaxel and Carboplatin plus Bevacizumab in StageIIIA-N2, IIIB, IV patients with Nonsquamous Non-Small-Cell Lung Cancerchemotherapy-na&iumlve StageIIIA-N2, IIIB, IV patients with nonsquamous non-small-cell lung cancerJPRN-UMIN000006809Akita University Graduate School of Medicine31
已完成
不适用
RCT PhaseII trial of Paclitaxel (P) and Carboplatin (C) plus continuous Gemcitabine (G) versus Gemcitabine (G) and Carboplatin (C) plus continuous Gemcitabine in untreated non-small cell lung cancer (NSCLC)on-small cell lung cancerJPRN-UMIN000008252Respiratory, Osaka University Hospital100